Articles > Reference > Dictionaries, Thesauruses, Pictures, and Press Releases > PR Newswire Europe press releases > November 2004

Article: BioPartners Submits an Application for Approval of Valtropin (TM) a Recombinant Human Growth Hormone in Europe.

Article from:
PR Newswire Europe
Article date:
November 29, 2004
Copyright

ZUG, Switzerland, November 29 /PRNewswire/ -- BioPartners, a global biopharmaceuticals company and one of the leaders in the emerging field of competitively priced biosimilar products has submitted a marketing authorisation application (MAA) to the European Medicines Evaluation Agency (EMEA) for Valtropin(TM) (somatropin), its recombinant human growth hormone developed in collaboration with LG Life Sciences (LGLS) of Korea.

The application for Valtropin in the treatment of paediatric and adult growth hormone deficiency (GHD) and other growth disorders is currently under regulatory review.

Commenting on the submission Professor Paul Saenger, Professor ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: BioPartners GmbH Signs 10 Year License and Supply ...
PR Newswire Europe;  February 22, 2005 ;     700+ words ... ... delivery of BioPartners' recombinant human growth hormone product ... than other growth hormone delivery ... agreement with BioPartners, with whom ... for Human Growth Hormone drugs is ... information on BioPartners please contact ...

Article: BioPartners Announces CHMP Positive Opinion for its ...
PR Newswire;  February 24, 2006 ;     700+ words ... ... February 24 /PRNewswire/ -- BioPartners, a global, privately owned biopharmaceuticals ... containing recombinant human growth hormone. Commenting on this, Professor ... our efforts and it demonstrates BioPartners' commitment and dedication to ...

Article: Biopartners presents three year safety and efficacy data ...
Clinical Trials Week;  October 6, 2008 ;     673 words ...Biopartners GmbH presented three ... data in children with growth hormone deficiency (GHD ... existing, daily human growth hormone products. Biopartners is also well advanced ... recombinant human growth hormone trials in children ...

Article: Biopartners' growth hormone, 3-year data.
Pharma Marketletter;  September 29, 2008 ;     420 words ... ... headquartered Biopartners GmbH presented ... recombinant human growth hormone LB03002 in children with growth hormone deficiency at ... existing products. Biopartners says it is also ... recombinant human growth hormone trials in children ...

Article: Polish biotech Bioton buys Biopartners.(Biopartners ...
Pharma Marketletter;  March 26, 2007 ;     700+ words ... ... shares, including the subsidiaries Biopartners GmbH (Switzerland) and Biopartners GmbH (Germany). Biopartners describes itself as a modern biotechnology ... Valtropin, a slow-release human growth hormone for the treatment of growth hormone ...

Article: Bioton acquires biopartners for $78m in stock, debt.
BioWorld International;  March 21, 2007 ;     700+ words ... ... Hausermann said. BioPartners, which has its roots ... release version of human growth hormone (HGH) in its pipeline ... Switzerland-based BioPartners obtained approval ... recombinant human growth hormone somatropin, which ... May 10, 2006.). BioPartners was formed in 2000 ...

Article: BioPartners has announced three year safety and efficacy ...
Inpharma Weekly;  September 27, 2008 ;     318 words ... ... profile comparable with existing daily human growth hormone products. [Reference] BioPartners GmbH. Biopartners Presents Three Year Safety ... Data for Sustained Release Recombinant Human Growth Hormone (LB03002) at ESPE 2008. Media Release ...

Article: Biopartners biosimilar rhGH Valtropin yields encouraging ...
Pharma Marketletter;  August 20, 2007 ;     344 words ... ... Baar, Switzerland-based biosimilars specialist Biopartners says that its recombinant human growth hormone (rhGH) Valtropin has demonstrated equivalent safety ... published in the September issue of Hormone Research, Biopartners said.

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives